Open-Label, Non-Mandatory Transitioning From Originator Etanercept to Biosimilar SB4: Six-Month Results From a Controlled Cohort Study

Lieke Tweehuysen; Victor J. B. Huiskes; Bart J. F. van den Bemt; Johanna E. Vriezekolk; Steven Teerenstra; Frank H. J. van den Hoogen; Cornelia H. van den Ende; Alfons A. den Broeder

doi:10.1002/art.40516

Open-Label, Non-Mandatory Transitioning From Originator Etanercept to Biosimilar SB4: Six-Month Results From a Controlled Cohort Study

Lieke Tweehuysen^*, Victor J. B. Huiskes, Bart J. F. van den Bemt, Johanna E. Vriezekolk, Steven Teerenstra, Frank H. J. van den Hoogen, Cornelia H. van den Ende, Alfons A. den Broeder

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

59 Citations (Web of Science)

Original language	English
Pages (from-to)	1408-1418
Number of pages	11
Journal	Arthritis & Rheumatology
Volume	70
Issue number	9
DOIs	https://doi.org/10.1002/art.40516
Publication status	Published - 1 Sep 2018

Keywords

NATIONWIDE NONMEDICAL SWITCH
RHEUMATOID-ARTHRITIS
DISEASE-ACTIVITY
SELF-EFFICACY
INFLAMMATORY ARTHRITIS
CLINICAL-OUTCOMES
DANBIO REGISTRY
INFLIXIMAB
EXPERIENCE
CT-P13

Access to Document

10.1002/art.40516

Cite this

Tweehuysen, L., Huiskes, V. J. B., van den Bemt, B. J. F., Vriezekolk, J. E., Teerenstra, S., van den Hoogen, F. H. J., van den Ende, C. H., & den Broeder, A. A. (2018). Open-Label, Non-Mandatory Transitioning From Originator Etanercept to Biosimilar SB4: Six-Month Results From a Controlled Cohort Study. Arthritis & Rheumatology, 70(9), 1408-1418. https://doi.org/10.1002/art.40516

Tweehuysen, Lieke ; Huiskes, Victor J. B. ; van den Bemt, Bart J. F. ; Vriezekolk, Johanna E. ; Teerenstra, Steven ; van den Hoogen, Frank H. J. ; van den Ende, Cornelia H. ; den Broeder, Alfons A. / Open-Label, Non-Mandatory Transitioning From Originator Etanercept to Biosimilar SB4 : Six-Month Results From a Controlled Cohort Study. In: Arthritis & Rheumatology. 2018 ; Vol. 70, No. 9. pp. 1408-1418.

@article{c354198199b24a3dbd8ee28df4e910ea,

title = "Open-Label, Non-Mandatory Transitioning From Originator Etanercept to Biosimilar SB4: Six-Month Results From a Controlled Cohort Study",

keywords = "NATIONWIDE NONMEDICAL SWITCH, RHEUMATOID-ARTHRITIS, DISEASE-ACTIVITY, SELF-EFFICACY, INFLAMMATORY ARTHRITIS, CLINICAL-OUTCOMES, DANBIO REGISTRY, INFLIXIMAB, EXPERIENCE, CT-P13",

author = "Lieke Tweehuysen and Huiskes, {Victor J. B.} and {van den Bemt}, {Bart J. F.} and Vriezekolk, {Johanna E.} and Steven Teerenstra and {van den Hoogen}, {Frank H. J.} and {van den Ende}, {Cornelia H.} and {den Broeder}, {Alfons A.}",

year = "2018",

month = sep,

day = "1",

doi = "10.1002/art.40516",

language = "English",

volume = "70",

pages = "1408--1418",

journal = "Arthritis & Rheumatology",

issn = "2326-5191",

publisher = "Wiley",

number = "9",

}

Open-Label, Non-Mandatory Transitioning From Originator Etanercept to Biosimilar SB4 : Six-Month Results From a Controlled Cohort Study. / Tweehuysen, Lieke; Huiskes, Victor J. B.; van den Bemt, Bart J. F.; Vriezekolk, Johanna E.; Teerenstra, Steven; van den Hoogen, Frank H. J.; van den Ende, Cornelia H.; den Broeder, Alfons A.

In: Arthritis & Rheumatology, Vol. 70, No. 9, 01.09.2018, p. 1408-1418.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Open-Label, Non-Mandatory Transitioning From Originator Etanercept to Biosimilar SB4

T2 - Six-Month Results From a Controlled Cohort Study

AU - Tweehuysen, Lieke

AU - Huiskes, Victor J. B.

AU - van den Bemt, Bart J. F.

AU - Vriezekolk, Johanna E.

AU - Teerenstra, Steven

AU - van den Hoogen, Frank H. J.

AU - van den Ende, Cornelia H.

AU - den Broeder, Alfons A.

PY - 2018/9/1

Y1 - 2018/9/1

KW - NATIONWIDE NONMEDICAL SWITCH

KW - RHEUMATOID-ARTHRITIS

KW - DISEASE-ACTIVITY

KW - SELF-EFFICACY

KW - INFLAMMATORY ARTHRITIS

KW - CLINICAL-OUTCOMES

KW - DANBIO REGISTRY

KW - INFLIXIMAB

KW - EXPERIENCE

KW - CT-P13

U2 - 10.1002/art.40516

DO - 10.1002/art.40516

M3 - Article

C2 - 29609207

VL - 70

SP - 1408

EP - 1418

JO - Arthritis & Rheumatology

JF - Arthritis & Rheumatology

SN - 2326-5191

IS - 9

ER -